|
|
|
FDA Home Page | Search
FDA Site | FDA A-Z Index | Contact
FDA
Food and Drug Administration
Office of Public Affairs
5600 Fishers Lane
Rockville, MD 20857
This public calendar is issued by the Food and Drug Administration. It lists meetings held by the FDA policy makers with persons outside the executive branch of the Federal Government.
 |
February 2, 2004 |
|
|||
|---|---|---|---|---|---|
FDA Official and Title |
Date and Site |
Other FDA Participants |
Non-FDA Participants |
Subject |
|
Jesse Goodman, M.D., Director, Center for Biologics Evaluation and Research |
1/26/04 Bethesda, MD |
Karen Midthun, M.D., Deputy for Medicine, CBER; Roland Levandowski, M.D., Office of Vaccines Research & Review, CBER |
Aventis (by telecon) |
Discussion of product development issues of interest to FDA |
|
Daniel E. Troy, Chief Counsel |
1/20/04 Rockville, MD |
Elizabeth Dickinson, Fred Ansell, Barr Wiener, OCC; Peter Rickman, John Grace, Rita Hassall, Cecelia Parcese, Gary Buehler, Dave Read, OGD |
Rich Cooper, Kevin Hardy, Glenn Pfaterhauer, Williams & Connolly |
Par Pharmaceuticals - Generic Latanoprost |
|
Daniel E. Troy, Chief Counsel |
1/27/04 Rockville, MD |
Eric Blumberg, Kim Dettelbach, Karen Schifter, OCC; Gary Buehler, Cecilia Panse, Dave Read, Greg Davis, CDER |
Jay R. Deshmukh, Ranbaxy; Ana C. Reves, Richard M. Cooper, Williams & Connolly |
Ranbaxy/Fluconozale |
|
Daniel E. Troy, Chief Counsel |
1/29/04 Rockville, MD |
Erica Keyes, OCC |
Donald E. Segal, Robert G. Pinco, Buchanan Ingersoll |
Merck, Germany/enzcamene |
|